The Trump administration has a new idea for changing drug rebates. That doesn't mean it's abandoning its earlier proposals

The Trump administration announced last week that, in an effort to lower drug costs for seniors, some “rebates” would be passed on to Medicare recipients at the pharmacy counter. At first blush, it sounded like a new version of the administration’s previous pledge to upend the pharmacy benefit manager industry and the system of “rebates,” which lawmakers and drug makers have blamed for high prices.